Carrimycin - CISMeF

Preferred Label : Carrimycin;

NCIt synonyms : Shengjimycin; Biotechspiramycin;

NCIt definition : A 16-membered macrolide antibiotic, with potential antibacterial and immunomodulatory activities. Upon administration, carrimycin targets and binds to bacterial ribosomes, thereby inhibiting protein synthesis. Carrimycin may be active against some Gram-positive bacteria and Mycobacterium tuberculosis. It may also have immunomodulatory activity, presumably through a different mechanism, which has not yet been characterized.;

UNII : K5E0V85NB9;

Drug name : Bite;

Details

Origin ID

C173568;

UMLS CUI

C0965458;

Automatic exact mappings (from CISMeF team)
- bites and stings [MeSH Descriptor]
Currated CISMeF NLP mapping
- carrimycin [MeSH Supplementary Concept]
- carrimycin [MeSH concept]
Semantic type(s)
- Antibiotic [UMLS semantic type]
- Biologically Active Substance [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- carrimycin [MeSH Supplementary Concept]
- carrimycin [MeSH concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]
- NCIt COVID-19 Agent Terminology [NCIt concept]
- NCIt COVID-19 Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients